These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multiple squamous cell carcinomas of the oral cavity in a young patient with graft-versus-host disease following allogenic bone marrow transplantation. Montebugnoli L; Gissi DB; Marchetti C; Foschini MP Int J Oral Maxillofac Surg; 2011 May; 40(5):556-8. PubMed ID: 21163622 [TBL] [Abstract][Full Text] [Related]
3. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Atsuta Y; Suzuki R; Yamashita T; Fukuda T; Miyamura K; Taniguchi S; Iida H; Uchida T; Ikegame K; Takahashi S; Kato K; Kawa K; Nagamura-Inoue T; Morishima Y; Sakamaki H; Kodera Y; Ann Oncol; 2014 Feb; 25(2):435-41. PubMed ID: 24399081 [TBL] [Abstract][Full Text] [Related]
4. High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan. Chen MH; Chang PM; Li WY; Hsiao LT; Hong YC; Liu CY; Gau JP; Liu JH; Chen PM; Chiou TJ; Tzeng CH Bone Marrow Transplant; 2011 Apr; 46(4):567-72. PubMed ID: 20622906 [TBL] [Abstract][Full Text] [Related]
5. Association of squamous cell carcinoma of the oral cavity in allogeneic hematopoietic stem cell transplant recipients. Reddy NM; Sullivan MA; Hahn TE; Battiwalla M; Smiley SL; McCarthy PL Bone Marrow Transplant; 2007 Nov; 40(9):907-9. PubMed ID: 17724441 [No Abstract] [Full Text] [Related]
6. Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation. Tamma R; Limongelli L; Maiorano E; Pastore D; Cascardi E; Tempesta A; Carluccio P; Mastropasqua MG; Capodiferro S; Covelli C; Pentenero M; Annese T; Favia G; Specchia G; Ribatti D Ann Hematol; 2019 Apr; 98(4):979-986. PubMed ID: 30519712 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Chaulagain CP; Sprague KA; Pilichowska M; Cowan J; Klein AK; Kaul E; Miller KB Bone Marrow Transplant; 2019 Apr; 54(4):560-566. PubMed ID: 30127467 [TBL] [Abstract][Full Text] [Related]
8. A case of upper gingiva carcinoma with chronic graft-versus-host disease after allogenic bone marrow transplantation. Tsushima F; Sakurai J; Harada H Aust Dent J; 2015 Sep; 60(3):404-7. PubMed ID: 26211810 [TBL] [Abstract][Full Text] [Related]
9. Impact of pre-transplant use of antibiotics on the graft-versus-host disease in adult patients with hematological malignancies. Lee MW; Yeon SH; Heo BY; Kwon J; Ryu H; Lee HJ; Yun HJ; Jo DY; Song IC Hematology; 2021 Dec; 26(1):96-102. PubMed ID: 33459581 [TBL] [Abstract][Full Text] [Related]
10. Oral malignancies following HSCT: graft versus host disease and other risk factors. Demarosi F; Lodi G; Carrassi A; Soligo D; Sardella A Oral Oncol; 2005 Oct; 41(9):865-77. PubMed ID: 16084755 [TBL] [Abstract][Full Text] [Related]
11. Clinical and histopathological features of the oral mucosa in allogeneic haematopoietic stem cell transplantation patients. Demarosi F; Lodi G; Carrassi A; Moneghini L; Sarina B; Sardella A Exp Oncol; 2007 Dec; 29(4):304-8. PubMed ID: 18199988 [TBL] [Abstract][Full Text] [Related]
12. P16-positive secondary tongue squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: A case report and literature review. Wu T; Liu Z; Yong X; Mei G; Jiang Q; Fang M; Li P; Zhang Z; Tao R Oral Oncol; 2021 Oct; 121():105399. PubMed ID: 34217620 [TBL] [Abstract][Full Text] [Related]
13. Oral manifestations compatible with chronic graft-versus-host disease in patients with Fanconi anemia. Grein Cavalcanti L; Fuentes Araújo RL; Bonfim C; Torres-Pereira CC Biol Blood Marrow Transplant; 2015 Feb; 21(2):275-80. PubMed ID: 25316110 [TBL] [Abstract][Full Text] [Related]
14. Influence of Previous Inflammatory Bowel Disease on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Matched-Pair Analysis. Rabian F; Porcher R; Sicre de Fontbrune F; Lioure B; Laplace A; Nguyen S; Tabrizi R; Vigouroux S; Tomowiak C; Maillard N; Suarez F; Delage J; Peffault de Latour R; Socié G; Biol Blood Marrow Transplant; 2016 Sep; 22(9):1721-1724. PubMed ID: 27246370 [TBL] [Abstract][Full Text] [Related]
15. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687 [TBL] [Abstract][Full Text] [Related]
16. In situ buccal carcinoma in a teenager after hematopoietic stem cell transplantation: A case report. Liu Y; Yuan W; Li M; Cheng L; Yang J; Yin B; Huang X Medicine (Baltimore); 2020 Oct; 99(43):e22781. PubMed ID: 33120791 [TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic stem cell transplantation following donor CIK cell infusion: A phase I study in patients with relapsed/refractory hematologic malignancies. Luo Y; Zeng HQ; Shen Y; Zhang P; Lou SF; Chen L; Deng JC Leuk Res; 2016 Sep; 48():6-10. PubMed ID: 27416327 [TBL] [Abstract][Full Text] [Related]
18. [Analysis of risk factors for relapse of 82 patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation]. Yu ZP; Ding JH; Chen BA; Wu F; Gao C; Sun YY; Chen J; Zhao G; Wang J; Li YF; Ding BH; Qian J Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):283-6. PubMed ID: 21575500 [TBL] [Abstract][Full Text] [Related]
19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
20. Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation. Ma SY; Au WY; Lie AK; Ng IO; Leung AY; Tse EW; Liang RH; Lau GK; Kwong YL Bone Marrow Transplant; 2004 Jul; 34(1):57-61. PubMed ID: 15156162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]